An expert review of the aetiology, assessment, and treatment of autism spectrum disorder,
and recommendations for diagnosis, management and service provision was coordinated …

The number of trials aimed at evaluating treatments for autism spectrum disorder has been
increasing progressively. However, it is not clear which outcome measures should be used …

Current evidence-based pharmacotherapy options in children with ASD are very limited, and
many have substantial adverse events. Clinicians should use pharmacotherapy as a part of …

Abstract Autism Spectrum Disorder (ASD) is a severe and lifelong neurodevelopmental
disorder, with high social costs and a dramatic burden on the quality of life of patients and …

Pharmacological Therapies for Autism Spectrum Disorder: A Review - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Abstract Rationale Autism spectrum disorders (ASDs) affect 1% of children, having
significant impact on health and social outcomes. Psychotropic medication use by …

This paper presents a systematic review, rating and synthesis of the empirical evidence for
the use of psychotropic medications in children with autism spectrum disorders (ASD). Thirty …

Objective The objective of this review was to examine prevalence and patterns of
psychopharmacotherapy in individuals with autism spectrum disorder (ASD). Method A …

Introduction: Individuals with autism spectrum disorder (ASD) commonly present for
treatment of emotional and behavioral disturbances associated with ASD's “core” symptoms …

This paper identifies instruments and measures that may be appropriate for randomized
clinical trials in participants with autism spectrum disorders (ASDs). The Clinical Global …